2014. Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease. Farmeconomia. Health economics and therapeutic pathways. 15, 3 (Sep. 2014). DOI:https://doi.org/10.7175/fe.v15i3.938.